Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Kinship influences sperm whale social organization within, but generally not among, social units.

Konrad CM, Gero S, Frasier T, Whitehead H.

R Soc Open Sci. 2018 Aug 29;5(8):180914. doi: 10.1098/rsos.180914. eCollection 2018 Aug.

2.

Variability of the inter-pulse interval in sperm whale clicks with implications for size estimation and individual identification.

Bøttcher A, Gero S, Beedholm K, Whitehead H, Madsen PT.

J Acoust Soc Am. 2018 Jul;144(1):365. doi: 10.1121/1.5047657.

PMID:
30075661
3.

Cultural turnover among Galápagos sperm whales.

Cantor M, Whitehead H, Gero S, Rendell L.

R Soc Open Sci. 2016 Oct 19;3(10):160615. eCollection 2016 Oct.

4.

Critical Decline of the Eastern Caribbean Sperm Whale Population.

Gero S, Whitehead H.

PLoS One. 2016 Oct 5;11(10):e0162019. doi: 10.1371/journal.pone.0162019. eCollection 2016.

5.

Socially segregated, sympatric sperm whale clans in the Atlantic Ocean.

Gero S, Bøttcher A, Whitehead H, Madsen PT.

R Soc Open Sci. 2016 Jun 8;3(6):160061. doi: 10.1098/rsos.160061. eCollection 2016 Jun.

6.

Individual, unit and vocal clan level identity cues in sperm whale codas.

Gero S, Whitehead H, Rendell L.

R Soc Open Sci. 2016 Jan 20;3(1):150372. doi: 10.1098/rsos.150372. eCollection 2016 Jan.

7.

The missing metric: quantifying contributions of reviewers.

Cantor M, Gero S.

R Soc Open Sci. 2015 Feb 11;2(2):140540. doi: 10.1098/rsos.140540. eCollection 2015 Feb.

8.

Calves as social hubs: dynamics of the social network within sperm whale units.

Gero S, Gordon J, Whitehead H.

Proc Biol Sci. 2013 Jun 5;280(1763):20131113. doi: 10.1098/rspb.2013.1113. Print 2013 Jul 22.

9.

Female philopatry in coastal basins and male dispersion across the North Atlantic in a highly mobile marine species, the sperm whale (Physeter macrocephalus).

Engelhaupt D, Hoelzel AR, Nicholson C, Frantzis A, Mesnick S, Gero S, Whitehead H, Rendell L, Miller P, De Stefanis R, Cañadas A, Airoldi S, Mignucci-Giannoni AA.

Mol Ecol. 2009 Oct;18(20):4193-205. doi: 10.1111/j.1365-294X.2009.04355.x. Epub 2009 Sep 21.

PMID:
19769692
10.

Synthesis and biological evaluation of carbocyclic analogues of lipid X: new nonpolar antagonists of LPS induced TNF production.

Augy-Dorey S, Billington DC, Camara JA, Gero SD, Sagnard I, Quiclet-Sire B, Ghezzi D.

Drug Des Discov. 1999 Jul;16(1):41-8.

PMID:
10466055
11.

D-glucosamine propanedithioacetal, an efficient chiral auxiliary in beta-lactam chemistry.

Anaya J, Gero SD, Grande M, Hernando JI, Laso NM.

Bioorg Med Chem. 1999 May;7(5):837-50.

PMID:
10400337
12.

Total synthesis of uracil analogues of sinefungin.

Barton DH, Géro SD, Lawrence F, Robert-Gero M, Quiclet-Sire B, Samadi M.

J Med Chem. 1992 Jan;35(1):63-7.

PMID:
1732534
13.

Rhizobium meliloti produces a family of sulfated lipooligosaccharides exhibiting different degrees of plant host specificity.

Schultze M, Quiclet-Sire B, Kondorosi E, Virelizer H, Glushka JN, Endre G, Géro SD, Kondorosi A.

Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):192-6.

14.

The effect of some drugs on in vitro cellular immune reactions and on circulating immune complexes in patients with myocardial infarction.

Horváth M, Mezey Z, Jósfay A, Nánay I, Varsányi M, Geró S.

J Investig Allergol Clin Immunol. 1991 Dec;1(6):404-10.

PMID:
1669600
15.

Comparative studies of D-myoinositol 1,4,5-trisphosphate and synthetic 6-deoxy D-myoinositol 1,4,5-trisphosphate: binding and calcium release activity in rat parotid microsomes.

Bonis D, Sezan A, Mauduit P, Dubreuil D, Cleophax J, Gero SD, Rossignol B.

Biochem Biophys Res Commun. 1991 Mar 29;175(3):894-900.

PMID:
1850995
16.

Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.

Safrany ST, Wojcikiewicz RJ, Strupish J, Nahorski SR, Dubreuil D, Cleophax J, Gero SD, Potter BV.

FEBS Lett. 1991 Jan 28;278(2):252-6.

17.

The effect of Etofibrate (Lipo-Merz) on "in vitro" cellular immune response and on lipid parameters of men with myocardial infarction and with arteriosclerosis obliterans.

Horváth M, Varsányl M, Jovanovich N, Romics L, Gerö S.

Allergol Immunopathol (Madr). 1990 Mar-Apr;18(2):95-9.

PMID:
2371944
18.

Studies on the correlation between the quantity of LDL-binding sites of platelets and the serum cholesterol levels.

Geró S, Szody E, Lengyel E, Simon G.

Adv Exp Med Biol. 1987;210:237-44. No abstract available.

PMID:
3591554
19.

Reply to the letter entitled 'Immunoglobulins containing circulating immune complexes in hypercholesterolaemic patients'.

Füst G, Szondy E, Gerö S.

Atherosclerosis. 1986 Oct;62(1):89. No abstract available.

PMID:
3778576
20.

Occurrence of anti-low density lipoprotein antibodies and circulating immune complexes in aged subjects.

Szondy E, Lengyel E, Mezey Z, Füst G, Gerö S.

Mech Ageing Dev. 1985 Feb;29(2):117-23.

PMID:
3974305
21.

Hypolipaemic effect and inhibition of lipid peroxidation by glunicate in rats on atherogenic diet.

Fehér J, Kiss A, Blazovics A, Szondy E, Toncsev H, Mathiász D, Gerö S.

Drugs Exp Clin Res. 1985;11(6):413-9.

PMID:
2941265
22.

Free and complexed anti-lipoprotein antibodies in vascular diseases.

Szondy E, Horváth M, Mezey Z, Székely J, Lengyel E, Füst G, Gerö S.

Atherosclerosis. 1983 Oct;49(1):69-77.

PMID:
6651914
23.

Role of the 1-amino group in aminocyclitol antibiotics: synthesis of 1-deaminogentamicin C2.

Philippe M, Quiclet-Sire B, Sepulchre AM, Gero SD, Loibner H, Streicher W, Stütz P, Moreau N.

J Antibiot (Tokyo). 1983 Mar;36(3):250-5.

24.

1-N-acylation of gentamicin C1a by a cyclic, chiral gamma-amino-alpha-hydroxy acid related to the (S)-4-amino-2-hydroxybutyric acid.

Philippe M, Sepulchre AM, Gero SD, Loibner H, Streicher W, Stutz P.

J Antibiot (Tokyo). 1982 Nov;35(11):1507-12.

25.
26.

Serial measurement of circulating immune complexes in myocardial infarction.

Szondy E, Mezey Z, Füst G, Székely J, Gerö S.

Br Heart J. 1981 Jul;46(1):93-8.

27.

Cell-mediated and humoral immune response in various vascular diseases.

Horváth M, Onody C, Gerö S.

Allergol Immunopathol (Madr). 1980 Mar-Apr;8(2):81-6.

PMID:
7457288
28.

[Effect of clofibrate therapy on serum lipids and lipoproteins].

Romics L, Szondy E, Gerö S.

Orv Hetil. 1980 Feb 10;121(6):321-3. Hungarian. No abstract available.

PMID:
7366989
29.

[Immune reactions in vascular diseases].

Horváth M, Onody K, Gerö S.

Orv Hetil. 1979 Sep 30;120(39):2351-7. Hungarian. No abstract available.

PMID:
523118
30.

[The effect of clofibrate (Miscleron) and pyridinol carbamate (Prodectin) on immunologic factors in experimental arteriosclerosis].

Szondy E, Horváth M, Füst G, Fehér J, Link E, Gerö S.

Orv Hetil. 1979 Jun 10;120(23):1391-2. Hungarian. No abstract available.

PMID:
492681
31.

Synthesis of alpha-linked 2',3'-dideoxy-2'-fluoro-pseudo-disaccharides related to aminocyclitol-glycoside antibiotics.

Vass G, Rolland A, Cleophax J, Mercier D, Quiclet B, Gero SD.

J Antibiot (Tokyo). 1979 Jun;32(6):670-2. No abstract available.

32.

The preparation of 1 D-2,6-dideoxy-[1-3H]-streptamine.

Mercier D, Gero SD, Barnett JE.

J Antibiot (Tokyo). 1979 Jan;32(1):81-2. No abstract available.

33.

The effect of clofibrate and pyridinol carbamate on the circulating immune complexes and cellular immune response in experimental atherosclerosis.

Szondy E, Horváth M, Füst G, Link E, Fehér J, Gerö S.

Atherosclerosis. 1978 Nov;31(3):251-7.

PMID:
718735
34.

Changes induced by vascular antigens in the aorta of guinea-pigs: immunological and morphological studies.

Fehér J, Horváth M, Fehér E, Szondy E, Onody K, Gerö S.

Br J Exp Pathol. 1978 Jun;59(3):237-47.

35.

Studies on the occurrence of circulating immune complexes in vascular diseases.

Füst G, Szondy E, Székely J, Nánai I, Gerö S.

Atherosclerosis. 1978 Feb;29(2):181-90.

PMID:
646847
36.

Sub-unit assembly in the biosynthesis of neomycin. The synthesis of 5-O-beta-D-ribofuranosyl and 4-O-beta-D-ribofuranosyl-2,6-dideoxystreptamines.

Pearce CJ, Akhtar M, Barnett JE, Mercier D, Sepulchre AM, Gero SD.

J Antibiot (Tokyo). 1978 Jan;31(1):74-81.

37.
38.

[Study of circulating immune complexes in vascular diseases (preliminary report)].

Füst G, Székely J, Szondy E, Gerö S.

Orv Hetil. 1977 Jun 26;118(26):1520-3. Hungarian. No abstract available.

PMID:
876637
39.

Circulating immune complexes in vascular diseases.

Füst G, Székely J, Gerö S.

Lancet. 1977 Jan 22;1(8004):193-4. No abstract available.

PMID:
64721
40.

Immunological factors in vascular diseases.

Gerö S, Szondy E, Füst G, Horváth M, Székely J.

Prog Biochem Pharmacol. 1977;13:283-6. No abstract available.

PMID:
928429
41.

The role of the pseudo-disaccharide neamine as an intermediate in the biosynthesis of neomycin.

Pearce CJ, Barnett JE, Anthony C, Akhtar M, Gero SD.

Biochem J. 1976 Dec 1;159(3):601-6.

42.

A chiral synthesis of D-(+)-2,6-dideoxystreptamine and its microbial incorporation into novel antibiotics.

Cleophax J, Gero SD, Leboul J, Akhtar M, Barnett JE, Pearce CJ.

J Am Chem Soc. 1976 Oct 27;98(22):7110-2. No abstract available.

PMID:
965673
43.

A fail-safe formula for problem solving.

Gero SV, Haffke ED.

Nursing. 1976 Oct;6(10):74-6, 78. No abstract available.

PMID:
1049011
44.

[The incidence of ischemic vascular diseases in primary hyperlipoproteinemia (study of 218 patients)].

Romics L, Szigeti A, Varsányi-Nagy M, Gerö S.

Orv Hetil. 1976 Mar 23;117(21):1274-6. Hungarian. No abstract available.

PMID:
1272572
45.

Immunological studies with aortic and venous tissue antigens. II. Antibodies to vascular antigens.

Gero S, Szekely J, Szondy E, Seregelyi E.

Paroi Arterielle. 1975 Dec;3(2):89-92.

PMID:
1234649
46.

Immunological studies with aortic and venous tissue antigens. I. The antigen structure of vascular tissues.

Szondy E, Jobbagy A, Link E, Gero S.

Paroi Arterielle. 1975 Dec;3(2):81-7.

PMID:
1234648
47.

A facile synthesis of derivatives of lividosamine, a component of lividomycin B.

Jegou E, Cleophax J, Leboul J, Gero SD.

Carbohydr Res. 1975 Dec;45:323-6. No abstract available.

PMID:
1044289
48.

[Immunological factors in cardiovascular diseases].

Gerö S, Székely J, Szondy E, Horváth M.

Z Gesamte Inn Med. 1975 Nov 15;30(22):252-4. German.

PMID:
813409
49.

[Effect of prostaglandin PGE1 on blood and tissue lipids in rabbit experimental arteriosclerosis].

Jacotot B, Gero S.

Pathol Biol (Paris). 1975 Nov;23(9):711-5. French.

PMID:
772549
50.

[Clinical observations on 218 cases of primary hyperlipoproteinemia].

Romics L, Szigeti A, Varsányi-Nagy M, Gerö S.

Orv Hetil. 1975 Oct 26;116(43):2527-31. Hungarian. No abstract available.

PMID:
1187131

Supplemental Content

Support Center